Previous 10 |
home / stock / npth:cc / npth:cc news
Total revenue increased by 9% to $15.4 million in the quarter Non-clinic revenue increased by 45% to $0.9 million in the quarter 13 th consecutive quarter of positive adjusted EBITDA (1) Fueling future growth with completion of three new fluoroscopy s...
Total revenue increased by 22% to $15.6 million in the quarter Same-clinic revenue growth (1) of 10% for the year ended December 31, 2021 Adjusted EBITDA growth (1) of 27% vs fiscal 2020 12 th consecutive quarter of positive adjusted EBITDA (1) ...
News, Short Squeeze, Breakout and More Instantly...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Mee...
Delivered record first quarter total revenue of $17.5 million, up 9% year-over-year Adjusted EBITDA (1) of $0.9 million, our 21 st consecutive quarter of positive adjusted EBITDA Improved cash flows, closing cash and cash equivalents balance of $2.6 million, up more than 3...
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Inv...